SGMO
Companies
NASDAQ
Sangamo Therapeutics Inc.
Health Care
$0.44
-$0.58 (-57.26%)
Price Chart
Overview
About SGMO
for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.
Market Cap
$119.2M
Volume
2.9M
Avg. Volume
3.5M
P/E Ratio
-2.1363637
Dividend Yield
0.00%
Employees
462.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.98
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, SGMO shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$119.2M
Volume2.9M
P/E Ratio-2.14
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025